ResMed Inc (RMD)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA and an Investment Account
Sell

$242.33

Buy

$259.57

arrow-down$-0.12 (-0.05%)

Prices updated at 12 Dec 2025, 22:36 EST
| Prices minimum 15 mins delay
|
Prices in USD

ResMed Inc is a part of the healthcare sector. It develops and distributes medical products for treating and diagnosing respiratory disorders.

Most recent dividend payment

0.600
Cash Dividend
13 Nov 2025
31 Oct 2025
13 Nov 2025
18 Dec 2025

Total dividend yield

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20252.26000.10
20242.02000.09
20231.84000.05
20221.72000.08
20211.6200-
20201.56000.05
20191.52000.06
20181.44000.06
20171.36000.10
20161.26000.07

Total dividend yield data table

Dividend yield (%)Buyback yield (%)
20250.880.87
20240.880.42
20231.07-
20220.83-
20210.62-
20200.73-
20190.98-
20181.260.33
20171.61-
20162.030.17

Dividend per share

% of earnings paid to shareholders

Dividend per share data table

YearDividend per share
20252.2600
20242.0200
20231.8400
20221.7200
20211.6200
20201.5600
20191.5200
20181.4400
20171.3600
20161.2600

% of earnings paid to shareholders data table

YearPayout ratio (%)
202522.42
202426.13
202329.27
202231.84
202146.63
202033.48
201951.72
201861.21
201754.47
201650.20
Latest Financial Report as of 12 Dec 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.